MonoSolRx Announces Hiring of Keith Kendall as Chief Financial Officer

Warren, NJ and Portage, IN – FOR IMMEDIATE RELEASE - MonoSol Rx announced today the hiring of Keith J. Kendall as its new Senior Vice President and Chief Financial Officer.

Mr. Kendall brings to MonoSolRx over 20 years of financial and business leadership experience essential to the current and future growth needs of the company. Most recently Mr. Kendall was the Vice President and Managing Director for the Americas at Hewlett Packard Financial Services. Prior to Hewlett Packard Financial Services Keith was a part of AT&T Capital Corp. from its inception in 1985 until its ultimate sale in 1998. At the time of the sale Mr. Kendall was the President of both AT&T Credit Corporation as well as NCR Credit Corporation.

“Keith brings the necessary senior management and financial experience to help seamlessly grow MonoSolRx LLC while also fulfilling the company’s need for more rigorous and sophisticated financial management. Keith’s experience in communicating with the appropriate capital markets will also be invaluable as the company moves forward” said A. Mark Schobel, Chief Executive Officer.

Mr. Kendall commented: “I am looking forward to providing the required financial leadership to continue MonoSolRx’s extraordinary growth over the last two years. I am confident that my financial experience will be synergistic with the company's strong technological base.”

About MonoSol Rx LLC
MonoSol Rx is a leading drug delivery company that uses film as a fast-dissolve oral drug delivery platform. MonoSol Rx LLC’s headquarters are based in Warren, New Jersey and its manufacturing facility is located in Portage, Indiana. MonoSol Rx previously acquired substantially all of the assets of Kosmos Pharma, including its extensive oral film intellectual property portfolio. MonoSol Rx's film oral dosage form looks like a postage stamp and dissolves readily on the tongue to deliver drugs to a patient, replacing the use of conventional tablets and capsules. MonoSol Rx currently markets a variety of products together with its marketing partners.

Please complete this form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing info@aquestive.com or by calling 1-833-AQUESTV

Please complete the form below and click SEND to receive a copy of “Overcoming Solubility and Permeability Challenges,” a case study detailing the achievements made by Aquestive’s formulation team to create the diazepam buccal film.

  • To subscribe to receive marketing updates about diazepam buccal film and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive direct marketing materials, you can contact us at any time by emailing info@aquestive.com or by calling 1-833-AQUESTV.

Please complete the form to receive a demonstration kit for our PharmFilm® technology.

  • To subscribe to receive marketing updates about our PharmFilm® technology and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive direct marketing materials, you can contact us at any time by emailing info@aquestive.com or by calling 1-833-AQUESTV.

Please complete this form:

  • To subscribe to receive marketing updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing info@aquestive.com or by calling 1-833-AQUESTV.

To learn how PharmFilm can transform your product or to begin a discussion about in-licensing, please complete the following form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing info@aquestive.com or by calling 1-833-AQUESTV